• Nenhum resultado encontrado

Rev. Soc. Bras. Med. Trop. vol.24 número2

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Soc. Bras. Med. Trop. vol.24 número2"

Copied!
1
0
0

Texto

(1)

R ev is ta da So cie dad e B ra sileira de M ed icin a T ropical 24(2): 117, abr-jun, 1991

COMUNICAÇÃO

MULTIPLE DRUG REGIMEN FOR SEVERE DIARRHEA

ASSOCIATED WITH

C R Y P T O S P O R I D I U M

IN

AIDS PATIENTS

Car los Brites, Edson D. Moreira Jr., José Car los Bina, Warren D. Johnson Jr. and Robert o Badaró

C r y p to s p o r id iu m is one of the most commonly

identified causes of chronic diarrhea and malabsorption in AIDS patients1. The severity of human cryptos­ poridiosis in AIDS patients can be correlated 'with the

degree of immune dysfunction that they present4 5. Several attempts at therapy of cryptosporidiosis have not been successsful and this disease remains without an effective treatment^ 7. This communication pre­

sents an alternative association therapy to control severe diarrhea in AIDS patients with cryptospori­ diosis.

We treated one patient with diarrhea caused by

C r y s p to s p o r id iu m with spiramycin without success.

After introduction of co-trimoxazole and doxycyclin for prophylaxis of P n e u m o c y s tis c a r in ii pneumonia and treatment of chlamydial urethritis, respectively, he had a complete recovery of symptoms.

After this first case, five consecutive patients with chronic diarrhea caused by C r y p to s p o r id iu m

were treated with a combination of spiramycin (50 mg/kg/day), doxycyclin (4 mg/kg/day) and co-trimoxa­ zole (TM P-SM X - 25/5 mg/kg/day).

All patients had a history of diarrhea of 30-45 days duration, (mean 38 days), with 10-15 episodes/- daily, and loss of more than 10% of their body weight

Prior to treatment, all patients had only Cryptos­

poridia identified in their stool (modified Ziehl- Neelsen staining)^ 3. Stc^l cultures on selective media for S a lm o n e lla , S h ig e lla , and C a m p y lo b a c te r were negative. Two patients showed progressive clinical improvement, after 5 days of treatment with a com­ plete recovery after 10 days. Two patients had an improvement after 8 days with disappearance of symptons after the 15 th day. The last patient had persistent severe diarrhea during three weeks after

Federal University of Bahia, Salvador, BA, Brazil. Cornell University Medical College, New York, NY, USA. This work was supported by the NIH Grant AI26506-03 Address: Dr. Roberto Badaró. Serviço de Imunologia do Hospital Prof. Edgaid Santos. R. João das Botas s/n Canela, 40140 Salvador, BA, Brasil.

Recebido para publicação em 04/10/90.

interruption of treatment An endoscopic study and biopsy of his colon showed no abnormalities.

AH five patients had a negative stool examina­ tion for C r y p to s p o r id iu m after completing treatment, and remained asymptomatic during three months of follow-up.

The medication was well tolerated, and no significant side-effects were observed. Two patients experienced mild nausea. We conclude that this combination therapy may be useful in the treatment of cryptosporidiosis in AIDS patients but requires fur­ ther evaluation.

REFERENCES

1. Center for Disease Control: Update: Treatment of cryptosporidiosis in patients with acquired immunode­ ficiency syndrome (AIDS). MMWR 33: 117, 1984. 2. Garcia LS, Bruckner DA, Brewer TC, Shimizu RY.

Techniques for the recovery and identification of C r y p ­ t o s p o r i d i o s i s oocysts from stool specimens. Journal of Clinical Microbiology 18: 185-90, 1983.

3. Ma P, Soave R. Three-step stool examination for cryp­ tosporidiosis in 10 homosexual men with protacted watery diarrhea. The Journal of Infectious Diseases 147: 824-828, 1983.

4. Margulis SJ, Honig CL, Soave R, Govani AF, Moura- dian JA, Jacobson IM. Biliary tract obstruction in the acquired immunodeficiency syndrome. Annals of Inter­ nal Medicine 105: 207-210, 1986.

5. Pitlik SD, Fainstein V, Garza D, Guarda L, Bolivar R, Rios A, Hopfer RL, Mausel PA. Human cryptospori­ diosis: Spectrum of disease. Report of six cases and review of the literature. Archives of Internal Medicine 143: 2269-2275, 1983.

6. Soave R, Armstrong D. Cryptosporidium and cryptos­ poridiosis. Reviews of Infectious Diseases 8: 1012- 1023, 1986.

7. Soave R, Dieterich D, Kotler D, Gassyur E, Tierney AR, Libes L, Legendre R. Oral diclurazil therapy for Cryptosporidiasis. In : Abstract of Sixth International

Conference on AIDS, San Francisco n.° ThB 520, June, 1990.

Referências

Documentos relacionados

In the first experiment, the mortality of nymphs in the test chambers with treated tiles was highest in the chamber with 80% RH, and lowest in the chambers with 50% and 60%

Embora o hamster não seja utilizado como modelo para a infecção chagásica, sob a alegação de sua reduzida capacidade de resposta imune protetora, é empregado nos estudos

Divisão de Malária, Superintendêndia de Campanhas de Saúde Pública-SUC AM, Ministério

The sections written by the author are most instructive particularly the initial part on history, biology, function and treatment I was fascinated to learn that even the

Em camundongos verificou-se que prazi­ quantel foi mais eficaz que oxamniquine, sendo que a percentagem de vermes sobreviventes foi de 4,6 para a primeira droga e 12,2 para

Virtually his last presentation of new work on expe­ rimental therapeutics of these two South American endemic protozoal diseases was given at the Núcleo of Medicine Tropical

Serological evidence of hantavirus infection in an urban area in Mato Grosso State, Brazil. Rev Soc Bras

Demographic and clinical characteristics of PLH without the use of ART according to sex and diagnosis of dyslipidemia Rev Soc Bras Med Trop 50(6):879-880,